APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sintilimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sintilimab Injection Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchSintilimab Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Sintilimab Injection Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Sintilimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sintilimab Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Sintilimab Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sintilimab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sintilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sintilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sintilimab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sintilimab Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sintilimab Injection market include Innovant Biologics, Inc.. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sintilimab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sintilimab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sintilimab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sintilimab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Sintilimab Injection Segment by Company

Innovant Biologics, Inc.

Sintilimab Injection Segment by Type

100mg/10ml

Others

Sintilimab Injection Segment by Application

Hospitals

Clinics

Others

Sintilimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sintilimab Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sintilimab Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sintilimab Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Sintilimab Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sintilimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sintilimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sintilimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sintilimab Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sintilimab Injection industry.

Chapter 3: Detailed analysis of Sintilimab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sintilimab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sintilimab Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sintilimab Injection Industry Trends Table 2. Sintilimab Injection Industry Drivers Table 3. Sintilimab Injection Industry Opportunities and Challenges Table 4. Sintilimab Injection Industry Restraints Table 5. Global Sintilimab Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sintilimab Injection Revenue Share by Company (2021-2026) Table 7. Global Sintilimab Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sintilimab Injection Sales Volume Share by Company (2021-2026) Table 9. Global Sintilimab Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sintilimab Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sintilimab Injection Key Company Manufacturing Base & Headquarters Table 12. Global Sintilimab Injection Company, Product Type & Application Table 13. Global Sintilimab Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sintilimab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg/10ml Table 18. Significant Companies of Others Table 19. Global Sintilimab Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Sintilimab Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Sintilimab Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Sintilimab Injection Sales Volume Share by Type (2021-2026) Table 23. Global Sintilimab Injection Sales Volume Share by Type (2027-2032) Table 24. Global Sintilimab Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sintilimab Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sintilimab Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sintilimab Injection Sales Value Share by Type (2021-2026) Table 28. Global Sintilimab Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Sintilimab Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Sintilimab Injection Sales Volume by Application (2021-2026) & (k units) Table 34. Global Sintilimab Injection Sales Volume by Application (2027-2032) & (k units) Table 35. Global Sintilimab Injection Sales Volume Share by Application (2021-2026) Table 36. Global Sintilimab Injection Sales Volume Share by Application (2027-2032) Table 37. Global Sintilimab Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sintilimab Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sintilimab Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sintilimab Injection Sales Value Share by Application (2021-2026) Table 41. Global Sintilimab Injection Sales Value Share by Application (2027-2032) Table 42. Global Sintilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Sintilimab Injection Sales by Region (2021-2026) & (k units) Table 44. Global Sintilimab Injection Sales Market Share by Region (2021-2026) Table 45. Global Sintilimab Injection Sales by Region (2027-2032) & (k units) Table 46. Global Sintilimab Injection Sales Market Share by Region (2027-2032) Table 47. Global Sintilimab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sintilimab Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sintilimab Injection Sales Value Share by Region (2021-2026) Table 50. Global Sintilimab Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sintilimab Injection Sales Value Share by Region (2027-2032) Table 52. Global Sintilimab Injection Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Sintilimab Injection Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Sintilimab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Sintilimab Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sintilimab Injection Sales by Country (2021-2026) & (k units) Table 57. Global Sintilimab Injection Sales Market Share by Country (2021-2026) Table 58. Global Sintilimab Injection Sales by Country (2027-2032) & (k units) Table 59. Global Sintilimab Injection Sales Market Share by Country (2027-2032) Table 60. Global Sintilimab Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sintilimab Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Sintilimab Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sintilimab Injection Sales Value Market Share by Country (2027-2032) Table 64. Innovant Biologics, Inc. Company Information Table 65. Innovant Biologics, Inc. Business Overview Table 66. Innovant Biologics, Inc. Sintilimab Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Innovant Biologics, Inc. Sintilimab Injection Product Portfolio Table 68. Innovant Biologics, Inc. Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Sintilimab Injection Distributors List Table 72. Sintilimab Injection Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Sintilimab Injection Product Image Figure 2. Global Sintilimab Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sintilimab Injection Sales (2021-2032) & (k units) Figure 5. Global Sintilimab Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sintilimab Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg/10ml Image Figure 10. Others Image Figure 11. Global Sintilimab Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Sintilimab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sintilimab Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Sintilimab Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sintilimab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sintilimab Injection Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Sintilimab Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Sintilimab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sintilimab Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Sintilimab Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sintilimab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sintilimab Injection Sales Value Share by Application (2021-2032) Figure 26. Global Sintilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Sintilimab Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sintilimab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sintilimab Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sintilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sintilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sintilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sintilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sintilimab Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sintilimab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sintilimab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sintilimab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sintilimab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sintilimab Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sintilimab Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/10ml
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Innovant Biologics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sintilimab Injection Sales Value (2021-2032)
  4. 1.2.2 Global Sintilimab Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Sintilimab Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sintilimab Injection Market Dynamics
  1. 2.1 Sintilimab Injection Industry Trends
  2. 2.2 Sintilimab Injection Industry Drivers
  3. 2.3 Sintilimab Injection Industry Opportunities and Challenges
  4. 2.4 Sintilimab Injection Industry Restraints
3 Sintilimab Injection Market by Company
  1. 3.1 Global Sintilimab Injection Company Revenue Ranking in 2025
  2. 3.2 Global Sintilimab Injection Revenue by Company (2021-2026)
  3. 3.3 Global Sintilimab Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Sintilimab Injection Average Price by Company (2021-2026)
  5. 3.5 Global Sintilimab Injection Company Ranking (2024-2026)
  6. 3.6 Global Sintilimab Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Sintilimab Injection Company Product Type and Application
  8. 3.8 Global Sintilimab Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sintilimab Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sintilimab Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sintilimab Injection Market by Type
  1. 4.1 Sintilimab Injection Type Introduction
  2. 4.1.1 100mg/10ml
  3. 4.1.2 Others
  4. 4.2 Global Sintilimab Injection Sales Volume by Type
  5. 4.2.1 Global Sintilimab Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sintilimab Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sintilimab Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sintilimab Injection Sales Value by Type
  9. 4.3.1 Global Sintilimab Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sintilimab Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sintilimab Injection Sales Value Share by Type (2021-2032)
5 Sintilimab Injection Market by Application
  1. 5.1 Sintilimab Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Sintilimab Injection Sales Volume by Application
  6. 5.2.1 Global Sintilimab Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sintilimab Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sintilimab Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sintilimab Injection Sales Value by Application
  10. 5.3.1 Global Sintilimab Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sintilimab Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sintilimab Injection Sales Value Share by Application (2021-2032)
6 Sintilimab Injection Regional Sales and Value Analysis
  1. 6.1 Global Sintilimab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sintilimab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Sintilimab Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Sintilimab Injection Sales by Region (2027-2032)
  5. 6.3 Global Sintilimab Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sintilimab Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sintilimab Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sintilimab Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Sintilimab Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sintilimab Injection Sales Value (2021-2032)
  12. 6.6.2 North America Sintilimab Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sintilimab Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Sintilimab Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sintilimab Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sintilimab Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sintilimab Injection Sales Value (2021-2032)
  21. 6.9.2 South America Sintilimab Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sintilimab Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sintilimab Injection Sales Value Share by Country, 2025 VS 2032
7 Sintilimab Injection Country-level Sales and Value Analysis
  1. 7.1 Global Sintilimab Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sintilimab Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sintilimab Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Sintilimab Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Sintilimab Injection Sales by Country (2027-2032)
  6. 7.4 Global Sintilimab Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sintilimab Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sintilimab Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sintilimab Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sintilimab Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sintilimab Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sintilimab Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sintilimab Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sintilimab Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sintilimab Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sintilimab Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sintilimab Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sintilimab Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sintilimab Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sintilimab Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sintilimab Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sintilimab Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sintilimab Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sintilimab Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sintilimab Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sintilimab Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sintilimab Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sintilimab Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sintilimab Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sintilimab Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sintilimab Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sintilimab Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sintilimab Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sintilimab Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sintilimab Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sintilimab Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sintilimab Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sintilimab Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Innovant Biologics, Inc.
  2. 8.1.1 Innovant Biologics, Inc. Company Information
  3. 8.1.2 Innovant Biologics, Inc. Business Overview
  4. 8.1.3 Innovant Biologics, Inc. Sintilimab Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Innovant Biologics, Inc. Sintilimab Injection Product Portfolio
  6. 8.1.5 Innovant Biologics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sintilimab Injection Value Chain Analysis
  2. 9.1.1 Sintilimab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sintilimab Injection Sales Mode & Process
  6. 9.2 Sintilimab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sintilimab Injection Distributors
  9. 9.2.3 Sintilimab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst